Young Blood Transfusions To Reverse Aging? Sign Me Up!

A new startup provides blood transfusions from young people to improve cognitive and neurological functions.

Tim HayesContributing Editor, Healthcare Packaging

Jun 15th, 2017

Blood transfusions can reverse aging. / Image: HBO

Blood transfusions can reverse aging. / Image: HBO

It sounds like science fiction, but a June 9^th Newsweek article discussed the new trend of using blood from the young to revitalize the old. The concept, which was parodied recently on an episode of Silicon Valley, actually has some compelling studies behind it. In 2014, Stanford University researchers infused young blood plasma in mice to rejuvenate synaptic plasticity and improve cognitive function.

Jesse Karmazin, a physician and graduate of Stanford’s medical school, believes this concept can work on humans. His company, Ambrosia LLC, charges adults (35+) $8,000 to be injected with blood plasma from people aged 16-25 as part of a clinical trial to test the anti-aging benefits of plasma transfusions. The article includes an interesting Q&A segment with Karmazin that is worth the read.

Safety in Aseptic Filling

FDA provides insight into common pitfalls found during inspections along with possible solutions.

FDA Releases Medical Devices Draft Guidance for Review

“The Transition Plan for Medical Devices Issued Emergency Use Authorizations During the Coronavirus Disease 2019 Public Health Emergency” guidance is now available for review.

Aseptic processing is one of the highest risk pharmaceutical operations, and thus requires a high level of control.

Pitfalls to Avoid in FDA Aseptic Manufacturing Inspections

From personnel to facility design to process, FDA policy advisor provides an outline of what facilities can improve on.

Serialization Master Data 60a571e0dae99

Counting Down the Top 10 Articles of 2021 - #1: Serialization 101

Join us as we look back at the most-read Healthcare Packaging stories of 2021. At #1, we’re going back to basics with an introductory look at serialization, required by pharma and medical device regulations to defend against counterfeiting.

Getty Images 1208358564 6073d57fe5816

Counting Down the Top 10 Articles of 2021 - #4: Data and AI Accelerate Digital Transformation

Join us as we look back at the most-read Healthcare Packaging stories of 2021. At #4, we cover the growing need for pharma manufacturing facilities to become digitalized to improve productivity and make the most of the ‘digitally native’ workforce.

FDA Discusses Nov. 2023 DSCSA Future State

At the HDA Traceability Online Seminar (Nov. 1-3, 2021), FDA’s Connie Jung, RPh, talked about how DSCSA continues to transform the pharmaceutical supply chain to preserve drug safety and security.

For product traceability, outbound scanning alone is expected to increase labor by a minimum of 12 to 15% based on recent time studies, per Cardinal Health.

Will Labor Requirements Increase in Meeting DSCSA Milestones?

With many companies either facing or concerned about labor shortages in manufacturing, an expert from Cardinal Health notes that outbound scanning alone may require a 12 to 15% increase in headcount in their operations.

Companies are adopting robotics and biometrics initiatives in drug product manufacturing and modern, robust aseptic processing technologies that afford tangible safety benefits to sterile products.

Applying Modern Technology to Pharmaceutical Production Facilities

Robotics, biometrics, and isolator technology are proving cleaner, faster, and safer than traditional manual methods.

Hp 107536 Surgical Tools Copy png 2

EU Regulators, Recycling, and Healthcare Plastics

Packaging suppliers speak about the openness of regulators to understand the slower nature of life science manufacturers in adopting more sustainable packaging.

Screen Shot 2021 11 01 At 7 04 22 Am

HDA Foundation Survey Reveals Uneven Progress on Rx Product Serialization

With 2023 DSCSA requirements around the corner, findings reveal aggregation has slowed. Now in its sixth year, this survey, released as part of HDA’s Traceability Online Seminar (November 1–3), assesses industry abilities to meet DSCSA requirements.

Four DSCSA Guidances Were Released this Summer: Are You Up to Date?

Read what’s new on DSCSA regarding suspect and illegitimate product, product identifiers, and enhanced drug distribution security at the package level.

Photo credited to Fresenius Kabi.

Fresenius Kabi Goes Above and Beyond DSCSA Requirements

With the support and standards of GS1 US, the pharmaceutical manufacturer fulfills customer needs for an additional system to ensure safe use of medication on a unit-of-use level.

Devices Getty Images 624567292 Sep Oct 2018

FDA Final Guidance: Form and Content of the Unique Device Identifier (UDI)

The document is intended to assist labelers and FDA-accredited issuing agencies in complying with unique device identifier (UDI) labeling requirements, including by clarifying FDA’s interpretation of certain requirements under 21 CFR 801.40.

Enforcement Policy Regarding Use of National Health Related Item Code and National Drug Code Numbers on Device Labels and Packages

Enforcement Policy Regarding Use of National Health Related Item Code and National Drug Code Numbers on Device Labels and Packages

Guidance for industry and FDA staff. Comments can be submitted.

As Marijuana Business Daily's Omar Sacirbey writes, “The move will allow greater research into marijuana and its potential medicinal properties.'

One Step Closer to Cannabis Access for Medical Research

After years of dragging their heels on approving marijuana cultivation applications for research, the DEA looks to be moving forward with licenses soon.

Expedite Med Device Approval with FDA’s New Program

Medical device manufacturers can potentially speed review by testing to recognized standards performed at a list of FDA-accredited labs released in April 2021. Watch this Take Five video to learn more.

Check out the links to our coverage of the 2021 PDA Annual Meeting. While the live event has passed, the event site is full of on-demand content covering pharmaceutical filling, supply chain considerations, vaccine manufacturing, and more through May 16.

2021 PDA Annual Meeting: Trend Roundup

The Parenteral Drug Association (PDA) virtual conference offered plenty of new perspectives in aseptic filling, flexible facilities, and more.

Could FDA's ASCA program save submission time and boost pre-market testing consistency in the medical device industry?

Demystifying FDA’s ASCA on Biocompatibility for Expedited Review

Live from MD&M BIOMEDigital: Medical device manufacturers can potentially speed review by testing to recognized standards performed at accredited labs.

5 Tips To Improve Your Remote/Hybrid Audits

Whether you’re a manufacturer or contract organization, audits are a key part of ensuring quality. Don’t overlook these tips from our 'Take Five with HCP' video when switching from in-person supplier audits to virtual or hybrid audits in the pandemic.

Pda Dk Blue Tag Below

PDA to Collaborate with Deloitte and U.S. FDA to Improve the Quality of Compounded Drugs

Courses to cover many PDA areas of expertise, including aseptic processing.

More in Regulatory

Getty Images 488635873

PDA Post-Approval Change Issues and Impacts Survey

This comprehensive survey includes data on the challenges presented by inconsistencies in how regulators treat post-approval changes and respondents’ experience with specific regulators.

Getty Images 136641043

Serialization Continues to Impact Pharma Automation Investments

Automation and IoT are on trend, as the industry continues to meet serialization regulations.

Govzilla Announces New Customer Platform and Company Name Change to Redica Systems

Fda Hi Res Copy

Saleable Returns Verification Delayed to 2023

Additional three-year delay: FDA guidance says distributors will not be required to verify the product identifier of returned drugs before resale until Nov. 27, 2023.

Gavel 5efd2dbada95c

Cannabis Policy Vote May Happen by End of 2020

The MORE Act would be historic in that it would remove cannabis from the Controlled Substances Act, opening a path for regulations to follow.

Alignment 90 Sep Oct 2018

Live from PDA/FDA: FDA Considers Incentivizing Quality Management Maturity (QMM)

The Agency is soliciting feedback from manufacturers on assessing and rewarding QMM through Oct. 2020. Reduced audit frequency may one day be an incentive for high performers.

C Ph I Fo P On White With Dates

CPhI Festival of Pharma 2020 in October

Former FDA commissioner Dr. Scott Gottlieb to address industry on sustainable innovation at the two-week long event. Sessions will cover affordable medicines, supply change resiliency, AI, Vaccine production, and more.

Smithers tests med devices

Smithers, a leading provider of testing, consulting, information, and compliance services, has announced the formation of the Medical Device Testing division.

Med Devices and the FDA: Extended Deadline, Worker Safety

In extending UDI compliance dates for low-risk products, FDA cited challenges related to COVID-19. CDRH also issued recommendations for personnel safety in med device manufacturing.

FDA Commissioner Dr. Stephen Hahn

New FDA Insight Podcast on Emerging Topics

First guest: FDA commissioner Dr. Stephen Hahn on fighting COVID-19 at FDA.

Quick Hits: Allergan is Seeking Women with Recalled Breast Implants

Allergan recalled breast implants more than 10 months ago; now they are trying to find the women who still have them.

Fitbit Ventilator

Quick Hits: FDA Gives Emergency Approval to Fitbit’s Ventilator

The wearable tech company developed a new ventilator to help treat the current health crisis.